Indeed, the pathogen seems like ancient history — but as recent developments indicate, tuberculosis isn’t done with us yet.

清华大学药学院刘刚教授课题组发文报道了一种基于结核分枝杆菌特异性铁离子转运蛋白IrtAB的新型荧光探针清华大学药学院最新科研动态news近期，... 近期，清华大学药学院刘刚教授课题组在ACS Central ...

Mammalian hosts coordinate various cell death pathways as part of the immune defense system against pathogens including ...

Tuberculosis (TB) is a serious infectious disease caused by the bacterium Mycobacterium tuberculosis. While multidrug treatment regimens are the standard of care, the lengthy treatment schedule and ...

A new mRNA vaccine against tuberculosis (TB) is showing favorable results in preclinical trials. With only one currently ...

Metaba, LLC ( and MAX BioPharma, Inc. ( are pleased to announce significant progress in their collaboration to develop ...

Australian researchers have developed a new mRNA vaccine for tuberculosis, showing effective results in mice. The vaccine ...

Around 1.5 million patients succumb to the disease caused by the bacterium Mycobacterium tuberculosis (Mtb). The novel ...

David Ussery and Brian Delavan discuss bioinformatics into TB surveillance, presenting a new approach to tackling this ...

Over 200 visitors interacted with each other over themes of drug resistant tuberculosis, extra-pulmonary TB and developments ...